Rubius Therapeutics, Inc. Operating Income 2018-2022 | RUBY
Rubius Therapeutics, Inc. operating income from 2018 to 2022. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
| Rubius Therapeutics, Inc. Annual Operating Income (Millions of US $) |
|
|---|---|
| 2022 | $-178 |
| 2021 | $-195 |
| 2020 | $-166 |
| 2019 | $-170 |
| 2018 | $-92 |
| 2017 | $-43 |
| 2016 | $-11 |
| Rubius Therapeutics, Inc. Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2022-12-31 | $-23 |
| 2022-09-30 | $-62 |
| 2022-06-30 | $-43 |
| 2022-03-31 | $-51 |
| 2021-12-31 | $-54 |
| 2021-09-30 | $-50 |
| 2021-06-30 | $-50 |
| 2021-03-31 | $-41 |
| 2020-12-31 | $-40 |
| 2020-09-30 | $-40 |
| 2020-06-30 | $-38 |
| 2020-03-31 | $-49 |
| 2019-12-31 | $-45 |
| 2019-09-30 | $-48 |
| 2019-06-30 | $-41 |
| 2019-03-31 | $-34 |
| 2018-12-31 | $-29 |
| 2018-09-30 | $-28 |
| 2018-06-30 | $-20 |
| 2018-03-31 | $-15 |
| 2017-09-30 | $-12 |
| 2017-06-30 | $-9 |
